Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors

Amerigo Rossi, Laena Frechette, Devin Miller, Eirwen Miller, Ciaran Friel, Anne Van Arsdale, Juan Lin, Viswanathan Shankar, Dennis Y.S. Kuo, Nicole S. Nevadunsky

Research output: Contribution to journalArticle

Abstract

Objective: Endometrial cancer survivors are the least physically active of all cancer survivor groups and exhibit up to 70% obesity. While studies suggest lifestyle interventions result in improved health outcomes, recruitment and availability of these programs are limited. The purpose was to evaluate the acceptability and validity of the Fitbit Alta™ physical activity monitor (Fitbit) for socioculturally diverse endometrial cancer survivors. Methods: Thirty endometrial cancer survivors were given wrist-worn Fitbits to wear for 30 days. Participants then returned the Fitbits, completed the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Technology Acceptance Questionnaire, and answered qualitative prompts. Correlations between daily Fitbit step counts, demographic factors, body mass index (BMI), and GLTEQ Index, were analyzed using Stata 13.0. Concordance Correlation Coefficient using U statistics was used to examine convergent validity. Results: Twenty-five participants completed the study. Mean age was 62 ± 9 years. Mean BMI was 32 ± 9 kg·m−2. Self-identified race/ethnicity was 36% Hispanic, 36% non-Hispanic white, 16% non-Hispanic black and 12% Asian. Participants wore the Fitbits a median of 93% of possible days. Median daily Fitbit step count was 5325 (IQR: 3761–8753). Mean Technology Acceptance score was 2.8 ± 0.5 out of 4.0. Younger (<65 years) and employed participants were more likely to achieve at least 6000 daily steps (p < 0.05). There was no correlation (CCC = 0.00, p = 0.99) between step count and GLTEQ Index. Most free responses reflected positive experiences. Conclusions: The Fitbits were well accepted in this sample. Self-reported physical activity was not associated with steps recorded. The physical activity data indicate an insufficiently active population.

LanguageEnglish (US)
JournalGynecologic Oncology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Endometrial Neoplasms
Survivors
Exercise
Leisure Activities
Body Mass Index
Technology
Wrist
Hispanic Americans
Life Style
Obesity
Demography
Surveys and Questionnaires
Health
Population
Neoplasms

Keywords

  • Endometrial cancer
  • Fitbit
  • Obesity
  • Physical activity tracker
  • Wearable technology

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors. / Rossi, Amerigo; Frechette, Laena; Miller, Devin; Miller, Eirwen; Friel, Ciaran; Van Arsdale, Anne; Lin, Juan; Shankar, Viswanathan; Kuo, Dennis Y.S.; Nevadunsky, Nicole S.

In: Gynecologic Oncology, 01.01.2018.

Research output: Contribution to journalArticle

@article{df5f164e03df4f539a11082306675f4b,
title = "Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors",
abstract = "Objective: Endometrial cancer survivors are the least physically active of all cancer survivor groups and exhibit up to 70{\%} obesity. While studies suggest lifestyle interventions result in improved health outcomes, recruitment and availability of these programs are limited. The purpose was to evaluate the acceptability and validity of the Fitbit Alta™ physical activity monitor (Fitbit) for socioculturally diverse endometrial cancer survivors. Methods: Thirty endometrial cancer survivors were given wrist-worn Fitbits to wear for 30 days. Participants then returned the Fitbits, completed the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Technology Acceptance Questionnaire, and answered qualitative prompts. Correlations between daily Fitbit step counts, demographic factors, body mass index (BMI), and GLTEQ Index, were analyzed using Stata 13.0. Concordance Correlation Coefficient using U statistics was used to examine convergent validity. Results: Twenty-five participants completed the study. Mean age was 62 ± 9 years. Mean BMI was 32 ± 9 kg·m−2. Self-identified race/ethnicity was 36{\%} Hispanic, 36{\%} non-Hispanic white, 16{\%} non-Hispanic black and 12{\%} Asian. Participants wore the Fitbits a median of 93{\%} of possible days. Median daily Fitbit step count was 5325 (IQR: 3761–8753). Mean Technology Acceptance score was 2.8 ± 0.5 out of 4.0. Younger (<65 years) and employed participants were more likely to achieve at least 6000 daily steps (p < 0.05). There was no correlation (CCC = 0.00, p = 0.99) between step count and GLTEQ Index. Most free responses reflected positive experiences. Conclusions: The Fitbits were well accepted in this sample. Self-reported physical activity was not associated with steps recorded. The physical activity data indicate an insufficiently active population.",
keywords = "Endometrial cancer, Fitbit, Obesity, Physical activity tracker, Wearable technology",
author = "Amerigo Rossi and Laena Frechette and Devin Miller and Eirwen Miller and Ciaran Friel and {Van Arsdale}, Anne and Juan Lin and Viswanathan Shankar and Kuo, {Dennis Y.S.} and Nevadunsky, {Nicole S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ygyno.2018.04.560",
language = "English (US)",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors

AU - Rossi, Amerigo

AU - Frechette, Laena

AU - Miller, Devin

AU - Miller, Eirwen

AU - Friel, Ciaran

AU - Van Arsdale, Anne

AU - Lin, Juan

AU - Shankar, Viswanathan

AU - Kuo, Dennis Y.S.

AU - Nevadunsky, Nicole S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Endometrial cancer survivors are the least physically active of all cancer survivor groups and exhibit up to 70% obesity. While studies suggest lifestyle interventions result in improved health outcomes, recruitment and availability of these programs are limited. The purpose was to evaluate the acceptability and validity of the Fitbit Alta™ physical activity monitor (Fitbit) for socioculturally diverse endometrial cancer survivors. Methods: Thirty endometrial cancer survivors were given wrist-worn Fitbits to wear for 30 days. Participants then returned the Fitbits, completed the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Technology Acceptance Questionnaire, and answered qualitative prompts. Correlations between daily Fitbit step counts, demographic factors, body mass index (BMI), and GLTEQ Index, were analyzed using Stata 13.0. Concordance Correlation Coefficient using U statistics was used to examine convergent validity. Results: Twenty-five participants completed the study. Mean age was 62 ± 9 years. Mean BMI was 32 ± 9 kg·m−2. Self-identified race/ethnicity was 36% Hispanic, 36% non-Hispanic white, 16% non-Hispanic black and 12% Asian. Participants wore the Fitbits a median of 93% of possible days. Median daily Fitbit step count was 5325 (IQR: 3761–8753). Mean Technology Acceptance score was 2.8 ± 0.5 out of 4.0. Younger (<65 years) and employed participants were more likely to achieve at least 6000 daily steps (p < 0.05). There was no correlation (CCC = 0.00, p = 0.99) between step count and GLTEQ Index. Most free responses reflected positive experiences. Conclusions: The Fitbits were well accepted in this sample. Self-reported physical activity was not associated with steps recorded. The physical activity data indicate an insufficiently active population.

AB - Objective: Endometrial cancer survivors are the least physically active of all cancer survivor groups and exhibit up to 70% obesity. While studies suggest lifestyle interventions result in improved health outcomes, recruitment and availability of these programs are limited. The purpose was to evaluate the acceptability and validity of the Fitbit Alta™ physical activity monitor (Fitbit) for socioculturally diverse endometrial cancer survivors. Methods: Thirty endometrial cancer survivors were given wrist-worn Fitbits to wear for 30 days. Participants then returned the Fitbits, completed the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Technology Acceptance Questionnaire, and answered qualitative prompts. Correlations between daily Fitbit step counts, demographic factors, body mass index (BMI), and GLTEQ Index, were analyzed using Stata 13.0. Concordance Correlation Coefficient using U statistics was used to examine convergent validity. Results: Twenty-five participants completed the study. Mean age was 62 ± 9 years. Mean BMI was 32 ± 9 kg·m−2. Self-identified race/ethnicity was 36% Hispanic, 36% non-Hispanic white, 16% non-Hispanic black and 12% Asian. Participants wore the Fitbits a median of 93% of possible days. Median daily Fitbit step count was 5325 (IQR: 3761–8753). Mean Technology Acceptance score was 2.8 ± 0.5 out of 4.0. Younger (<65 years) and employed participants were more likely to achieve at least 6000 daily steps (p < 0.05). There was no correlation (CCC = 0.00, p = 0.99) between step count and GLTEQ Index. Most free responses reflected positive experiences. Conclusions: The Fitbits were well accepted in this sample. Self-reported physical activity was not associated with steps recorded. The physical activity data indicate an insufficiently active population.

KW - Endometrial cancer

KW - Fitbit

KW - Obesity

KW - Physical activity tracker

KW - Wearable technology

UR - http://www.scopus.com/inward/record.url?scp=85046143876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046143876&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2018.04.560

DO - 10.1016/j.ygyno.2018.04.560

M3 - Article

JO - Gynecologic Oncology

T2 - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

ER -